Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Severe explosion in Syracuse home injures 10, investigation underway An explosion occurred at a residence in Syracuse, New York, resulting in severe injuries and critical conditions for… byPallavi MadhirajuJune 19, 2024